Cayman Pharma is Europe's most reliable and versatile source for Prostaglandin APIs//FDA approved.
01 1Cayman Pharma s r.o.
02 1Piramal Healthcare UK Limited
03 1TIEN (Tianjin) Pharmaceutical Co. Ltd
01 2Cloprostenol Sodium
02 1Cloprostenol sodium
01 1China
02 1Czech Republic
03 1India
Cayman Pharma is Europe's most reliable and versatile source for Prostaglandin APIs//FDA approved.
NDC Package Code : 61556-001
Start Marketing Date : 2003-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 24584-1114
Start Marketing Date : 2022-02-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 69870-093
Start Marketing Date : 2015-11-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (10g/10g)
Marketing Category : BULK INGREDIENT
A Cloprostenol Sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cloprostenol Sodium, including repackagers and relabelers. The FDA regulates Cloprostenol Sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cloprostenol Sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cloprostenol Sodium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Cloprostenol Sodium supplier is an individual or a company that provides Cloprostenol Sodium active pharmaceutical ingredient (API) or Cloprostenol Sodium finished formulations upon request. The Cloprostenol Sodium suppliers may include Cloprostenol Sodium API manufacturers, exporters, distributors and traders.
click here to find a list of Cloprostenol Sodium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Cloprostenol Sodium as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Cloprostenol Sodium API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Cloprostenol Sodium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Cloprostenol Sodium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Cloprostenol Sodium NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Cloprostenol Sodium suppliers with NDC on PharmaCompass.
We have 3 companies offering Cloprostenol Sodium
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
